203 related articles for article (PubMed ID: 29950151)
1. High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC.
Yang J; Kong P; Yang J; Jia Z; Hu X; Wang Z; Cui H; Bi Y; Qian Y; Li H; Wang F; Yang B; Yan T; Ma Y; Zhang L; Cheng C; Song B; Li Y; Xu E; Liu H; Gao W; Wang J; Liu Y; Zhai Y; Chang L; Wang Y; Zhang Y; Shi R; Liu J; Wang Q; Cheng X; Cui Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818781405. PubMed ID: 29950151
[TBL] [Abstract][Full Text] [Related]
2. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2.
Zhang L; Gao Y; Zhang X; Guo M; Yang J; Cui H; Kong P; Niu X; Bi Y; Xu J; Yan T; Ma Y; Yang J; Qian Y; Wang F; Li H; Liu F; Cheng X; Cui Y
Theranostics; 2020; 10(24):11339-11358. PubMed ID: 33042286
[No Abstract] [Full Text] [Related]
3. Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis.
Hijiya N; Shibata T; Daa T; Hamanaka R; Uchida T; Matsuura K; Tsukamoto Y; Nakada C; Iha H; Inomata M; Moriyama M
Pathol Int; 2017 Feb; 67(2):83-90. PubMed ID: 27976824
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA-125a-5p in lung cancer.
Gao Y; Zhang G; Liu J; Li H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760213
[TBL] [Abstract][Full Text] [Related]
5. Integrin α5 promotes tumor progression and is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
Xie JJ; Guo JC; Wu ZY; Xu XE; Wu JY; Chen B; Ran LQ; Liao LD; Li EM; Xu LY
Hum Pathol; 2016 Feb; 48():69-75. PubMed ID: 26772401
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of B7-H6 in esophageal squamous cell carcinoma.
Zhou H; Dong J; Guo L; Wang X; Wang K; Cai X; Yang S
Sci Rep; 2019 Dec; 9(1):18122. PubMed ID: 31792298
[TBL] [Abstract][Full Text] [Related]
7. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma.
Guo W; Zhang F; Shao F; Wang P; Li Z; Yang X; He Z; Shi S; Gao Y; He J
Hum Pathol; 2019 Feb; 84():291-298. PubMed ID: 30296523
[TBL] [Abstract][Full Text] [Related]
10. High endothelin-converting enzyme-1 expression independently predicts poor survival of patients with esophageal squamous cell carcinoma.
Wu CF; Lee CT; Kuo YH; Chen TH; Chang CY; Chang IW; Wang WL
Tumour Biol; 2017 Sep; 39(9):1010428317725922. PubMed ID: 28945168
[TBL] [Abstract][Full Text] [Related]
11. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
12. TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Di S; Li M; Ma Z; Guo K; Li X; Yan X
Pathol Res Pract; 2019 Jun; 215(6):152415. PubMed ID: 31064720
[TBL] [Abstract][Full Text] [Related]
13. CD68 and interleukin 13, prospective immune markers for esophageal squamous cell carcinoma prognosis prediction.
Li J; Zhang BZ; Qin YR; Bi J; Liu HB; Li Y; Cai MY; Ma S; Chan KW; Xie D; Guan XY
Oncotarget; 2016 Mar; 7(13):15525-38. PubMed ID: 26771842
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of red cell distribution width in esophageal squamous cell carcinoma.
Hirahara N; Tajima Y; Fujii Y; Hyakudomi R; Yamamoto T; Ishitobi K; Taniura T; Kawabata Y
J Surg Res; 2018 Oct; 230():53-60. PubMed ID: 30100040
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
16. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
[TBL] [Abstract][Full Text] [Related]
17. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
[TBL] [Abstract][Full Text] [Related]
18. A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Wang C
J Cell Physiol; 2019 May; 234(5):6810-6819. PubMed ID: 30387125
[TBL] [Abstract][Full Text] [Related]
19. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
20. Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma.
Hamada J; Shoda K; Masuda K; Fujita Y; Naruto T; Kohmoto T; Miyakami Y; Watanabe M; Kudo Y; Fujiwara H; Ichikawa D; Otsuji E; Imoto I
Oncotarget; 2016 Mar; 7(13):17111-28. PubMed ID: 26958940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
